Louise Laporte
Overview
Explore the profile of Louise Laporte including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
407
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Benard E, Carceller A, Mayrand M, Lacroix J, Niyibizi J, Laporte L, et al.
J Med Virol
. 2025 Feb;
97(2):e70221.
PMID: 39912394
Little is known on the dynamics of human papillomavirus (HPV) viral load during pregnancy and on the impact of viral load on HPV vertical transmission. We described viral loads for...
2.
Nantel E, Mayrand M, Audibert F, Niyibizi J, Brassard P, Laporte L, et al.
Viruses
. 2024 Feb;
16(2).
PMID: 38400078
Human papillomavirus (HPV) can be vertically transmitted. Our objective was to measure the association between the mode of delivery and the detection of HPV in infants. We used data collected...
3.
Khayargoli P, Mayrand M, Niyibizi J, Audibert F, Laporte L, Lacaille J, et al.
Viruses
. 2024 Feb;
16(2).
PMID: 38400073
Recent evidence shows increased preterm birth risk with human papillomavirus-16 (HPV16) infection during pregnancy. This study aimed to measure the association between HPV16 viral load during pregnancy and preterm birth....
4.
Khayargoli P, Niyibizi J, Mayrand M, Audibert F, Monnier P, Brassard P, et al.
JAMA Pediatr
. 2023 May;
177(7):684-692.
PMID: 37213128
Importance: The prevalence of human papillomavirus (HPV) infection during pregnancy and its risk of transmission to newborns are not well documented. Objective: To ascertain the prevalence of HPV in pregnant...
5.
Sangare M, Baril J, de Pokomandy A, Klein M, Thomas R, Tremblay C, et al.
Clin Infect Dis
. 2023 Feb;
76(11):1879-1888.
PMID: 36722329
Background: The impact of different therapeutic classes of drugs in antiretroviral therapy (ART) regimens on the CD4/CD8 ratio is not well documented in people treated for HIV. The objective of...
6.
Hassan G, Laporte L, Paquin S, Menard C, Sahai A, Masse B, et al.
Diagnostics (Basel)
. 2022 Dec;
12(12).
PMID: 36552957
Introduction: One of the most effective diagnostic tools for pancreatic cancer is endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) or biopsy (EUS-FNB). Several randomized clinical trials have compared different EUS tissue sampling...
7.
Niyibizi J, Mayrand M, Audibert F, Monnier P, Brassard P, Laporte L, et al.
Sex Transm Infect
. 2022 Mar;
98(8):575-581.
PMID: 35246478
Objective: Human papillomavirus (HPV) has been associated with adverse pregnancy outcomes but placental HPV infection has been rarely studied. The objective was to determine the proportion of HPV-positive placentas and...
8.
Niyibizi J, Mayrand M, Audibert F, Monnier P, Brassard P, Laporte L, et al.
JAMA Netw Open
. 2021 Sep;
4(9):e2125308.
PMID: 34524433
Importance: Preterm birth remains a leading cause of perinatal mortality and lifelong morbidity worldwide. The cause of most preterm births is unknown, although several infectious processes have been implicated. Objective:...
9.
Diop N, Bonong P, Buteau C, Duval M, Lacroix J, Laporte L, et al.
Vaccines (Basel)
. 2021 Jul;
9(6).
PMID: 34200239
Background: Epstein-Barr virus (EBV) and cytomegalovirus (CMV) infections can have serious consequences during the period of aplasia and lymphopenia following hematopoietic stem cell transplantation (HSCT). Large pediatric cohort studies examining...
10.
Enok Bonong P, Buteau C, Duval M, Lacroix J, Laporte L, Tucci M, et al.
Pediatr Transplant
. 2021 Jun;
25(7):e14052.
PMID: 34076939
Background: Epstein-Barr virus (EBV) can cause severe disease following hematopoietic stem cell transplant (HSCT), including post-transplant lymphoproliferative disorder (PTLD). The objective was to analyze risk factors associated with post-transplant EBV...